Adenocarcinoma of the Esophagus Recruiting Phase 2 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0030040 (Adenocarcinoma of the Esophagus)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02037048FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal AdenocarcinomaTreatment